NCT04653740View on ClinicalTrials.gov

Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Advanced Breast Cancer
Interventions
PROCEDURE

specimen sample collection

"Before and during treatment, and at progression, collection of :~* Blood~* Exhaled air~* Saliva~* Sweat~* Tears~* Urine"

Trial Locations (1)

59020

Centre Oscar Lambret, Lille

All Listed Sponsors
collaborator

Laboratoire PRISM - Michel SALZET

UNKNOWN

lead

Centre Oscar Lambret

OTHER